Innovation / / 5 min read

NASA Twin ESCAPADE Probes Complete First Powered Earth Flybys Toward Mars as FDA Convenes Transcranial Ultrasound Roundtable

NASA reported that its twin ESCAPADE spacecraft completed the agency's first-ever powered Earth flybys at altitudes of 1,000 and 650 miles after a year in an L2 loiter orbit, setting course for Mars arrival in September 2027, while the US FDA and the Focused Ultrasound Foundation hosted a November 10 workshop on transcranial ultrasound for neurological and psychiatric therapies.

By 全球伯乐 News

Research and compilation

Share
On this page

Breaking the Two-Year Mars Launch Window: Twin ESCAPADE Probes Execute Powered Earth Slingshots at 1,000 and 650 Miles

NASA’s Science Mission Directorate announced that the agency’s twin ESCAPADE (Escape and Plasma Acceleration and Dynamics Explorers) spacecraft have each completed a powered Earth flyby, combining Earth’s gravity with an approximately 9-minute trans-Mars injection engine burn to slingshot toward the Red Planet for scheduled 11-minute Mars orbit insertion burns on September 7 and September 9, 2027.1 The first spacecraft executed its close approach and engine firing at 5:00 a.m. EST on November 7 at an altitude of roughly 1,000 miles above Earth, followed by its twin two days later at 6:00 a.m. EST on November 9 at an altitude of about 650 miles—marking the first time NASA has used a powered Earth gravity assist to propel a spacecraft toward Mars.1

AI-generated editorial illustration: a matte terracotta sphere with two brass miniature spacecraft models on a dark basalt slab beside a frosted-glass acoustic focusing dome and metal probe represent interplanetary gravity-assist maneuvers and transcranial ultrasound evaluation, not flight hardware or clinical devices.

AI-generated editorial illustration: a matte terracotta sphere with two brass miniature spacecraft models on a dark basalt slab beside a frosted-glass acoustic focusing dome and metal probe represent interplanetary gravity-assist maneuvers and transcranial ultrasound evaluation, not flight hardware or clinical devices.

Led by the University of California, Berkeley’s Space Sciences Laboratory (SSL) alongside Rocket Lab, Blue Origin, Embry-Riddle Aeronautical University, and Advanced Space under NASA’s low-cost SIMPLEx program, ESCAPADE validated a new interplanetary staging architecture.1 Launched from Cape Canaveral on November 13, 2025, when Earth and Mars were on opposite sides of the Sun, the twin probes spent a year in a kidney-bean-shaped 'loiter' orbit around Earth-Sun Lagrange point 2 (L2) roughly one million miles away, collecting magnetotail observations before returning to Earth once planetary alignment arrived.1 Lead mission designer Jeff Parker and principal investigator Rob Lillis noted that this loiter-and-slingshot strategy decouples Mars launches from rigid 26-month alignment windows; beginning in June 2028, the two orbiters will fly in coordinated formations around Mars to measure simultaneously from two locations how the solar wind drives Martian atmospheric loss.1

Non-Invasive Blood-Brain Barrier Opening and Neuromodulation: FDA Hosts November 10 Transcranial Ultrasound Workshop

Alongside NASA’s orbital mechanics milestone, US biomedical regulators convened on November 10, 2026 (9:00 a.m. to 5:00 p.m. ET), for a full-day hybrid public workshop in McLean, Virginia, co-sponsored by the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) and the Focused Ultrasound Foundation, titled 'Research Roundtable on the Development of Transcranial Ultrasound for Neurological and Psychiatric Applications'.2

According to the FDA workshop charter, transcranial ultrasound is advancing rapidly across non-invasive neuromodulation and transient blood-brain barrier (BBB) opening to facilitate targeted drug delivery, brain liquid biopsy, and neuro-oncology therapies.2 While not issuing new binding device clearances by itself, the November 10 roundtable convened clinical and acoustic engineering specialists to establish shared technical benchmarks on patient safety risks, nonclinical bench and animal testing, clinical trial design and outcome endpoints for both therapeutic and diagnostic transcranial ultrasound devices, and specific evaluation safeguards for pediatric patients.2

Source notes

  1. 2026-11-09 · NASA's ESCAPADE Completes Powered Earth Flybys, Now En Route to Mars · NASA Science Mission Directorate. ↩ ↩2 ↩3 ↩4 ↩5

  2. 2026-11-10 · FDA and the Focused Ultrasound Foundation Co-sponsored Public Workshop: Research Roundtable on the Development of Transcranial Ultrasound for Neurological and Psychiatric Applications - 11/10/2026 · U.S. Food and Drug Administration (FDA). ↩ ↩2 ↩3

Keep reading

More from the desk

Studio tabletop still life of three graduated brushed-brass blocks, a clear glass prism, and a dark green jadeite cylinder on veined white marble
Business/

EU Strikes Deal on Three-Tier 70% SFDR Sustainable Fund Categories as IMF Closes 58% of Open IEO Reform Actions

The Council of the European Union and the European Parliament reached a provisional agreement overhauling the Sustainable Finance Disclosure Regulation into sustainable, transition, and ESG basics categories with a 70% minimum investment threshold, while the IMF Executive Board concluded its 16th Periodic Monitoring Report on Independent Evaluation Office recommendations.

Studio tabletop still life of a clear glass microfluidic flow-cell slide, two amber glass reagent ampoules, and a brass cylinder on pale travertine stone
Innovation/

FDA Reviews Pathogen-Agnostic Sequencing Diagnostics as WHO GAP-f Advances Pediatric Medicines Roadmap and WIPO Signs 2027–2029 India IP Plan

The U.S. Food and Drug Administration Microbiology Devices Panel convened to evaluate pathogen-agnostic sequencing and agile bioinformatics for outbreak response, while the World Health Organization highlighted GAP-f pediatric formulation targets on World Children's Day and WIPO signed the 2027–2029 IP Action Plan with India covering AI analytics and dispute resolution.

Studio tabletop still life of a faceted clear optical glass cube, an unbranded titanium key blank, and a brass coaxial connector on dark basalt
Technology/

NIST Initiates TLS 1.3 Post-Quantum Revision and mDL Identity Guide as EU Launches First Cyber Resilience Act Standard and EDU-EDIC

The U.S. National Institute of Standards and Technology announced a major revision to SP 800-52 Rev. 2 for TLS 1.3 and post-quantum cryptography alongside draft SP 1800-42 for mobile driver licenses, while the European Commission published the first horizontal standard under the Cyber Resilience Act and launched the eight-nation EDU-EDIC digital education consortium.